Not Medicare Enrolled

Dr. Peter Dumas, MD

Gastroenterology · Venice, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
825 VENETIAN PKWY, Venice, FL 34285
9414835730
In practice since 2006 (19 years)
NPI: 1043245665 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dumas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dumas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dumas

Dr. Peter Dumas is a gastroenterology specialist in Venice, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dumas performed 20,708 Medicare services across 1,433 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dumas received a total of $11,447 from 43 pharmaceutical and/or device companies across 535 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dumas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in FL $11,447 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,708
Medicare services
Top 1% in FL for gastroenterology
1,433
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,090 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
17,700 $17 $43
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,430 $26 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
446 $92 $256
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
196 $60 $282
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
171 $101 $410
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
146 $124 $338
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
130 $63 $227
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
108 $205 $523
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $57 $182
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
64 $50 $133
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
52 $119 $339
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
43 $140 $379
External hemorrhoid removal by rubber banding
A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off.
36 $222 $582
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
27 $176 $379
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
26 $101 $268
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
25 $22 $58
Injection beneath large bowel lining via endoscope
A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine.
11 $19 $410
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
92.8% high complexity
2.3% medium
4.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,447
Total received (2018-2024)
Avg $1,635/year across 7 years
Top 14% in FL for gastroenterology
43
Companies
535
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,529 (92.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$918 (8.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$131
2023
$2,344
2022
$1,895
2021
$1,238
2020
$506
2019
$2,048
2018
$3,285

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$1,533
AbbVie Inc.
$1,397
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,137
ABBVIE INC.
$910
Takeda Pharmaceuticals U.S.A., Inc.
$843
FUJIFILM Medical Systems USA, Inc.
$756
Janssen Biotech, Inc.
$715
PFIZER INC.
$513
Celgene Corporation
$340
Allergan Inc.
$299
Ironwood Pharmaceuticals, Inc
$281
UCB, Inc.
$255
Medtronic USA, Inc.
$227
Ferring Pharmaceuticals Inc.
$193
GENZYME CORPORATION
$192
Braintree Laboratories, Inc.
$189
Intercept Pharmaceuticals, Inc.
$150
VIVUS LLC
$144
Axonics, Inc.
$137
Medtronic, Inc.
$121
Merck Sharp & Dohme Corporation
$114
Shionogi Inc
$114
Regeneron Pharmaceuticals, Inc.
$104
E.R. Squibb & Sons, L.L.C.
$75
FUJIFILM Healthcare Americas Corporation
$72
RedHill Biopharma Inc.
$68
Regeneron Healthcare Solutions, Inc.
$66
Covidien LP
$63
Gilead Sciences, Inc.
$59
Amgen Inc.
$49
VIVUS, Inc.
$47
QOL Medical, LLC
$45
Merck Sharp & Dohme LLC
$41
Ardelyx, Inc.
$36
Mauna Kea Technologies, Inc.
$27
Pharmacosmos Therapeutics Inc.
$25
Lilly USA, LLC
$23
Dova Pharmaceuticals
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Aries Pharmaceuticals, Inc.
$16
Nestle HealthCare Nutrition Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$12
GI Supply, Inc.
$12
Top 3 companies account for 35.5% of total payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Aemcolo · Amitiza · Axonics · BYSTOLIC · CLENPIQ · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Doptelet · ELEVIEW · ENTYVIO · ESD - Core Endoscopy · Entyvio · FUJIFILM · GATTEX · GI GENIUS · HUMIRA · Humira · IBSRELA · INFLECTRA · INTERSTIM · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · PANCREAZE · PLENVU · Pancreaze · PillCam · REBYOTA · REMICADE · RINVOQ · SKYRIZI · STELARA · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · Symproic · TRULANCE · Talicia · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $55 per 100 Medicare services performed
Looking for a gastroenterology specialist in Venice?
Compare gastroenterologists in the Venice area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
54
Per 100K population
12.0
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
4.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dumas is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement in the top 14% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dumas experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Dumas performed 17,700 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dumas receive payments from pharmaceutical companies?
Yes. Dr. Dumas received a total of $11,447 from 43 companies across 535 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dumas's costs compare to other gastroenterologists in Venice?
Dr. Dumas's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dumas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →